Application of the J-CTO Score to Intraplaque Guidewire Tracking-Based Recanalization for In-Stent Chronic Total Occlusions

Chieh-Yu Chen,Chi-Hung Huang,Jen-Fang Cheng,Chien-Lin Lee,Jiunn-Yang Chiang,Shih-Chi Liu,Chi-Jen Chang,Chia-Pin Lin,Cheng-Ting Tsai,Jun-Ting Liu,Chia-Ti Tsai,Yi-Chih Wang,Juey-Jen Hwang

DOI: https://doi.org/10.1101/2024.08.21.24312395

2024-08-22

Abstract:Background: The application of the J-CTO score for in-stent chronic total occlusion (CTO) recanalization remains unclear. We aimed to compare the role of J-CTO score in in-stent and de novo CTO interventions using intraplaque guidewire tracking techniques. Methods: The application of the J-CTO score to assess procedural feasibility and guidewire crossing time for in-stent (N=74, 14.6%) and de novo CTO (N=434, 85.4%) interventions was evaluated in consecutive 508 patients (64.1±11.6 years, 446 men). Failed intraplaque tracking (N=3) or guidewires crossing (N=35) was considered procedural failures (38/508=7.5%). Results: The procedural success rate for de novo CTOs significantly declined when the J-CTO score was >2 (85 vs. ≤2: 97%, p<0.001), but was comparable for in-stent CTOs (>2: 96 vs. ≤2: 100%, p=0.400). Among 470 patients with successful recanalization, the guidewire crossing time ≥30 minutes was required less for in-stent than for de novo CTOs (OR=0.40, 95% CI=0.18-0.86) with J-CTO score ≥2 in multivariate analysis. For those with successful antegrade-only wiring, the guidewire crossing time shown by Kaplan-Meier curves was significantly related to the J-CTO score for either in-stent (N=72) or de novo (N=370) CTOs (both p<0.001 by log-rank test). However, only blunt stump (15.0±5.6 min) and occlusion ≥20mm (16.2±5.6 min) were independent time-determining factors of guidewire crossing (both p<0.01) for in-stent CTOs. Conclusion: With the intraplaque tracking strategy, the effects of the J-CTO score on procedural feasibility and guidewire crossing time differ for in-stent and de novo CTOs. Therefore, the J-CTO score should be cautiously interpreted during in-stent CTO interventions.

Cardiovascular Medicine

What problem does this paper attempt to address?

The paper aims to address the following issues:

1. **Evaluate the application of the J-CTO score in in-stent chronic total occlusion (in-stent CTO)**: The paper attempts to compare the role of the J-CTO score in in-stent CTO and de novo CTO, particularly in the effectiveness of recanalization using the intraplaque guidewire tracking technique.

2. **Explore guidewire crossing time and procedural feasibility**: The study analyzes the impact of the J-CTO score on guidewire crossing time and procedural success rate, and investigates whether these factors differ between in-stent CTO and de novo CTO.

Main conclusions include:
- For de novo CTO, when the J-CTO score is greater than 2, the procedural success rate significantly decreases; however, this effect is not evident for in-stent CTO.
- In successful recanalization cases, for those with a J-CTO score of 2 and above, the guidewire crossing time for in-stent CTO is significantly shorter than for de novo CTO.
- The guidewire crossing time for in-stent CTO is related to the J-CTO score but is mainly influenced by a blunt stump and an occlusion length greater than 20 millimeters. This indicates that the J-CTO score should be interpreted with caution when assessing the procedural difficulty of in-stent CTO.

Through these analyses, the paper highlights the differences in the application of the J-CTO score in different types of CTO and suggests that more caution should be exercised when evaluating in-stent CTO.